Correction: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: Study protocol for a randomised controlled trial (Trials (2018) 19:670 DOI: 10.1186/s13063-018-3050-4)

Angelos G. Kolias*, Ellie Edlmann, Eric P. Thelin, Diederik Bulters, Patrick Holton, Nigel Suttner, Kevin Owusu-Agyemang, Yahia Z. Al-Tamimi, Daniel Gatt, Simon Thomson, Ian A. Anderson, Oliver Richards, Peter Whitfield, Monica Gherle, Karen Caldwell, Carol Davis-Wilkie, Silvia Tarantino, Garry Barton, Hani J. Marcus, Aswin ChariPaul Brennan, Antonio Belli, Simon Bond, Carole Turner, Lynne Whitehead, Ian Wilkinson, Peter J. Hutchinson

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

After publication of the original article [1], the authors notified that that one of the BNTRC institutional collaborator names was misspelled. Both incorrect and correct spellings are presented below.

Original languageEnglish
Article number175
JournalTrials
Volume20
Issue number1
DOIs
Publication statusPublished - 18 Mar 2019
Externally publishedYes

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Correction: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: Study protocol for a randomised controlled trial (Trials (2018) 19:670 DOI: 10.1186/s13063-018-3050-4)'. Together they form a unique fingerprint.

Cite this